This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
| less than a minute read
Reposted from A Fresh Take

Life sciences – what to watch in 2025

We asked more than 200 Freshfields lawyers – across geographies and practice areas: what are the 1-2 issues top of mind for you and your clients going into 2025?

Here are the ten topics most frequently identified as areas to watch in 2025.

  1. Antitrust – maintained levels of heightened scrutiny and enforcement.
  2. Global protectionism – trend of increased restrictions to continue?
  3. Drug pricing – ongoing refinement of government programs.
  4. US litigation – increased focus on diligence clauses. 
  5. EU litigation – changes and uncertainties. 
  6. EU/UK regulatory oversight – ongoing reform. 
  7. MedTech - ongoing expansion and evolving legal issues.
  8. Deal-making - recent trends in biopharma. 
  9. ESG - increasing regulation in life sciences sector.
  10. US public health agencies - landscape under the Trump administration. 

Read the full report here.

***

Many thanks to the numerous Freshfields lawyers who contributed to this piece.

To receive the latest ESG developments globally, subscribe to the Freshfields Sustainability Blog.

Tags

2024 elections, antitrust and competition, life sciences transactional, m&a, medtech, foreign investment, litigation, regulatory framework, life sciences, political change, us, uk, europe